Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Paper
  • Published:

Update on extracorporeal photochemotherapy for graft-versus-host disease treatment

Summary:

Pediatric experience with extracorporeal photochemotherapy (ECP) for graft-versus-host disease (GvHD) has mainly been reported by Italian and French groups. Data concerning 41 children with acute GvHD and 63 children affected by chronic GvHD are available. In 73 and 63% of them, respectively, improvement was observed, with addition of ECP to their immunosuppressive regimen. Treatment with ECP was associated with minimal side effects, even in the smallest of patients. In all responded pediatric patients, both with acute and chronic GvHD, ECP allowed progressive reduction or discontinuation of the concomitant pharmacological immunosuppressive therapy without an increase in GvHD acitivity. These data show that ECP is a useful therapy for children affected by GvHD resistant to conventional treatment and can be safely used.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Rossetti F, Zulian F, Dall'Arnico R et al. Extracorporeal photochemotherapy as single therapy for extensive, cutaneous, chronic graft-versus-host disease. Transplantation 1995; 59: 149–151.

    Article  CAS  Google Scholar 

  2. Rossetti F, Dall'Amico R, Crovetti G et al. Extracorporeal photochemistry for the treatment of graft-versus-host disease. Bone Marrow Transplant 1996; 18: 175–181.

    Google Scholar 

  3. Dall'Amico R, F Rossetti, F Zulian et al. Photopheresis in paediatric patients with drug-resistant chronic graft-versus-host disease. Br J Haematol 1997; 97: 848–854.

    Article  CAS  Google Scholar 

  4. Perotti C, L Torreta, G Viarengo et al. Feasibility and safety of a new technique of extracorporeal photochemotherapy: experience of 240 procedures. Haematologica 1999; 84: 237–241.

    CAS  PubMed  Google Scholar 

  5. Biagi E, Perseghin P, Buscemi F et al. Effectiveness of extracorporeal photochemotherapy in treating refractory chronic graft-versus-host disease. Haematologica 2000; 85: 329–330.

    CAS  Google Scholar 

  6. Salvaneschi L, Perotti C, Zecca M et al. Extracorporeal photochemotherapy for treatment of acute and chronic GVHD in childhood. Transfusion 2001; 41: 1299–1305.

    Article  CAS  Google Scholar 

  7. Perutelli P, Rivabella L, Lanino E et al. ATP downregulation in mononuclear cells from children with graft-versus-host disease following extracorporeal photochemotherapy. Haematologica 2002; 87: 335–336.

    PubMed  Google Scholar 

  8. Perseghin P, Dassi M, Balduzzi A et al. Mononuclear cell collection in patients undergoing extra-corporeal photo-chemotherapy for acute and chronic graft vs host disease: comparison between Cobe Spectra version 4.7 and 6.0 (Auto PBSC). J Clin Apheresis 2002; 17: 65–71.

    Article  Google Scholar 

  9. Messina C, Locatelli F, Lanino E et al. Extracorporeal photochemotherapy for paediatric patients with graft-versus-host disease after haematopoietic stem cell transplantation. Br J Haematol 2003; 122: 118–127.

    Article  CAS  Google Scholar 

  10. Schooneman F, Claise C . Treatment of graft versus host disease by photopheresis? Transfus Sci 1996; 17: 527–536.

    Article  CAS  Google Scholar 

  11. Besnier DP, Chabannes D, Mahe B et al. Treatment of graft-versus-host disease by extracorporeal photochemotherapy: a pilot study. Transplantation 1997; 64: 49–54.

    Article  CAS  Google Scholar 

  12. D'incan M, Kanold J, Halle P et al. Extracorporeal photopheresis as an alternative therapy for drug-resistant graft versus host disease: three cases. 2000; 127: 166–170.

  13. Halle P, Paillard C, D'Incan M et al. Successful extracorporeal photochemotherapy for chronic graft-versus-host disease in pediatric patients. J Hematother Stem Cell Res. 2002; 11: 501–512.

    Article  Google Scholar 

  14. Kanold J, Paillard C, Halle P et al. Extracorporeal photochemotherapy for graft versus host disease in pediatric patients. Transfus Apheresis Sci 2003; 28: 71–80.

    Article  Google Scholar 

  15. Kanold J, Halle P, Paillard C et al. Extracorporeal photochemotherapy for graft versus host disease in pediatric patients. Blood 2003: (Supp1. 102) (Abstract).

  16. Balda B, Kostantinov A, Starz H et al. Extracorporeal photochemotherapy as an effective treatment modality in chronic graft versus host disease. J Eur Acad Dermatol Venerol 1996; 7: 155–162.

    Article  Google Scholar 

  17. Looks A, Fuchs D, Rulke D et al. Successful treatment of acute graft versus host disease after bone marrow transplantation in 16-year-old girl with extracorporeal photopheresis. Onkologie 1997; 20: 340–342.

    Google Scholar 

  18. Miller K, Roberts T, Chan G et al. A novel reduced intensity regimen for allogeneic hematopoietic stem cell transplantation associated with a reduced incidence of graft-versus-host disease. Bone Marrow Transplant 2004; 33: 881–889.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Consortia

Corresponding author

Correspondence to J Kanold.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kanold, J., Messina, C., Halle, P. et al. Update on extracorporeal photochemotherapy for graft-versus-host disease treatment. Bone Marrow Transplant 35 (Suppl 1), S69–S71 (2005). https://doi.org/10.1038/sj.bmt.1704851

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1704851

Keywords

This article is cited by

Search

Quick links